Monthly Communication Report

Corporation:	GlaxoSmithKline Inc.
Associated registration:	953603-5088-74
Communication date:	2024-11-26
Posted date:	2024-12-16

Designated Public Office Holders who participated in the communication:	Amanda Ratz, Senior Advisor Deputy Minister's Office, Health Canada (HC) Greg Orencsak, Deputy Minister Health Canada (HC) Jill Norman , Director Centre for Communicable Diseases and Infection Control, Health Canada (HC)
List of Details Subject matter Detail Budget, Economic Development, Government Procurement, Health Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Health National Immunization Strategy. Advocacy to seek continued investment in vaccines funding and an overall strategy for prevention of disease in Canada. Health, Immigration Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030.
Responsible Officer who filed this communication report:	Sridhar Venkatesh
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.